Unknown

Dataset Information

0

Aberrant GIMAP2 expression affects oral squamous cell carcinoma progression by promoting cell cycle and inhibiting apoptosis.


ABSTRACT: GTPases of immunity-associated protein 2 (GIMAP2) is a GTPase family member associated with T cell survival. However, its mechanisms of action in oral squamous cell carcinoma (OSCC) remain largely unknown. Therefore, the present study aimed to elucidate the possible role of GIMAP2 in OSCC development by investigating its expression levels and molecular mechanisms in OSCC. Reverse transcription quantitative PCR, immunoblotting and immunohistochemistry indicated that GIMAP2 expression was significantly upregulated (P<0.05) in OSCC-derived cell lines and primary OSCC specimens compared with that in their normal counterparts. GIMAP2-knockdown OSCC cells exhibited decreased cell growth, which was associated with cyclin-dependent kinase (CDK)4, CDK6 and phosphorylated Rb downregulation and p53 and p21 upregulation. In addition to cell cycle arrest, GIMAP2 affected anti-apoptotic functions in GIMAP2-knockdown cells by upregulating Bcl-2 and downregulating Bax and Bak. These findings indicated that GIMAP2 may significantly influence OSCC development and apoptosis inhibition and thus is a potential biomarker of OSCC.

SUBMITTER: Komatsu M 

PROVIDER: S-EPMC8721858 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8670214 | biostudies-literature
| S-EPMC10647187 | biostudies-literature
| S-EPMC3299600 | biostudies-literature
| S-EPMC8592591 | biostudies-literature
| S-EPMC4849064 | biostudies-literature
| S-EPMC6628964 | biostudies-literature
| S-EPMC6436762 | biostudies-literature
| S-EPMC6073368 | biostudies-literature
| S-EPMC4816280 | biostudies-literature
2024-08-23 | PXD047535 | Pride